This project aims to address the underexplored potential for programmed cell death to promote, rather than limit inflammation. Building on existing collaborations and an innovative and multi-faceted approach, this project will expand our knowledge of the cross-talk between cell death and inflammatory signalling. This research will provide fundamental insights into the consequences of cell death and will benefit the health of Australians, as it will define novel drug targets for the biomedical industry.
|Effective start/end date||1/01/20 → 31/12/23|
- Cell death
- Innate Immunity